BGM
GPCR icon

Burkehill Global Management’s Structure Therapeutics GPCR Stock Holding History

Burkehill Global Management’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Hold
60,000
– – 0.12% 106
2026
Q1 		$2.89M Hold
60,000
– – 0.14% 107
2025
Q4 		$4.17M Buy
+60,000
New +$2.45M 0.27% 85

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Burkehill Global Management's GPCR Position: Q2 2026 in Review

Burkehill Global Management held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 60,000 shares worth $3.22M. The position accounts for 0.12% of the portfolio, ranked #106.

Burkehill Global Management first reported a position in GPCR in Q4 2025 and has held it in 3 quarters since. The position peaked at $4.17M in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Burkehill Global Management held 60,000 shares of Structure Therapeutics worth $3.22M as of Q2 2026.
  • Burkehill Global Management left its Structure Therapeutics share count unchanged in Q2 2026.
  • Structure Therapeutics made up 0.12% of Burkehill Global Management's portfolio in Q2 2026, its #106 holding.
  • Burkehill Global Management first reported a position in Structure Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Burkehill Global Management's Structure Therapeutics position peaked at $4.17M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Burkehill Global Management's 13F filing for Q2 2026, filed 14 Aug 2026.